Evidence map›Paper›PMID 27764728›Full record

ArticleVirology2016

HPV31 utilizes the ATR-Chk1 pathway to maintain elevated RRM2 levels and a replication-competent environment in differentiating Keratinocytes.

Daniel C Anacker, Heather L Aloor, Caitlin N Shepard, Gina M Lenzi, Bryan A Johnson, Baek Kim, Cary A Moody

Open access · greenAbstract read
In one paragraph

Article in Virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daniel C AnackerDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, North Carolina, USA.
Heather L AloorLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina, USA.
Caitlin N ShepardThe Center for Drug Discovery, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Gina M LenziThe Center for Drug Discovery, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Bryan A JohnsonDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, North Carolina, USA.
Baek KimThe Center for Drug Discovery, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Children's Healthcare of Atlanta, USA.
Cary A MoodyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, North Carolina, USA. Electronic address: camoody@med.unc.edu.
University of North Carolina at Chapel Hill · USEmory University · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Replication fidelity and lentiviral pathogenesisR01AI049781 · NIAID · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2002 to 2016
$4.9M
SAMHD1 controls dNTP pool and HIV sensitivity to NRTIsR01GM104198 · NIGMS · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2012 to 2018
$2.3M
Regulation of human papillomavirus replication by the DNA damage responseR01CA181581 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MOODY, CARY A · 2014 to 2018
$1.6M
NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA181581NIAID NIH HHS R01 AI049781NIGMS NIH HHS R01 GM104198NIGMS NIH HHS T32 GM008602
6 · The paper itself

Abstract

Productive replication of human papillomaviruses (HPV) is restricted to the uppermost layers of the differentiating epithelia. How HPV ensures an adequate supply of cellular substrates for viral DNA synthesis in a differentiating environment is unclear. Here, we demonstrate that HPV31 positive cells exhibit increased dNTP pools and levels of RRM2, a component of the ribonucleotide reductase (RNR) complex, which is required for de novo synthesis of dNTPs. RRM2 depletion blocks productive replication, suggesting RRM2 provides dNTPs for viral DNA synthesis in differentiating cells. We demonstrate that HPV31 regulates RRM2 levels through expression of E7 and activation of the ATR-Chk1-E2F1 DNA damage response, which is essential to combat replication stress upon entry into S-phase, as well as for productive replication. Our findings suggest a novel way in which viral DNA synthesis is regulated through activation of ATR and Chk1 and highlight an intriguing new virus/host interaction utilized for viral replication.

Indexed as

Virus ReplicationAtaxia Telangiectasia Mutated ProteinsCheckpoint Kinase 1DeoxyribonucleosidesDNA DamageDNA ReplicationHost-Pathogen InteractionsHuman papillomavirus 31HumansKeratinocytesPapillomavirus E7 ProteinsPapillomavirus InfectionsProtein DomainsRibonucleoside Diphosphate ReductaseAtaxia Telangiectasia Mutated ProteinsATR protein, humanCheckpoint Kinase 1CHEK1 protein, humanDeoxyribonucleosidesPapillomavirus E7 ProteinsRibonucleoside Diphosphate Reductaseribonucleotide reductase M2DNA damage responseHuman papillomavirusPathogenesisReplication

Identifiers

PMID27764728
PMCPMC5102796
OpenAlexW2532144537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.